11 - 13 June 2019, Helsinki, Finland.
As a pioneer when it comes to collaborating with digital health start-ups, Bayer is now taking the next step. Instead of one-off startup programs, it is now focusing on collaborating in specific digital health focus areas, e.g. digital therapeutics, AI for drug discovery, and patient engagement platforms to name a few. To do this, Bayer is combining the G4A programs and concentrating on longer-term collaborations and investments.
Senior people are statistically at greater risk of cognitive impairment, frailty and multiple chronic health conditions with consequences for their independence, their quality of life (and the one of their families) but also for the sustainability of health and social care systems.
A clinical study by Coventry and Warwickshire Partnership NHS Trust and Oxehealth has significantly reduced falls and saved time following Manor Hospital's introduction of the Digital Care Assistant, with benefits for patients, nurses and the organisation.
Royal Philips (NYSE: PHG, AEX: PHIA) revealed how dentists will be able to benefit from its new Philips Sonicare Teledentistry Solution, which uses the latest digital technology to enable remote dental assessment through an app. This illustrates Philips' ambition to support dentists in optimizing their dental practice and empower people to proactively take charge of their oral health through personalized digital innovation.
Allscripts (NASDAQ: MDRX) announced that Alfardan Group, one of the leading family-owned conglomerates in Qatar and Chicago-based Northwestern Medicine have selected Allscripts to provide ambulatory care services for the launch of its new project, Alfardan Medical with Northwestern Medicine.
Merck, a leading science and technology company, today announced a collaboration agreement with Iktos, for the use of its generative modelling artificial intelligence (AI) technology, in order to facilitate the rapid and cost-effective discovery and design of promising new compounds.